BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 164 filers reported holding BLUEBIRD BIO INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $130,814 | -7.6% | 43,031 | 0.0% | 0.00% | – |
Q2 2023 | $141,572 | +40.1% | 43,031 | +35.4% | 0.00% | – |
Q1 2023 | $101,038 | -54.0% | 31,773 | 0.0% | 0.00% | – |
Q4 2022 | $219,869 | +16.1% | 31,773 | +6.2% | 0.00% | – |
Q3 2022 | $189,337 | +46.8% | 29,911 | -4.0% | 0.00% | – |
Q2 2022 | $129,015 | -10.5% | 31,163 | +4.9% | 0.00% | – |
Q1 2022 | $144,103 | -60.1% | 29,712 | -17.8% | 0.00% | – |
Q4 2021 | $361,000 | -18.3% | 36,158 | +1.2% | 0.00% | – |
Q3 2021 | $442,000 | -63.7% | 35,729 | -6.1% | 0.00% | -100.0% |
Q2 2021 | $1,217,000 | +490.8% | 38,066 | +2803.6% | 0.00% | – |
Q2 2018 | $206,000 | -96.7% | 1,311 | -96.4% | 0.00% | -100.0% |
Q1 2018 | $6,152,000 | -6.4% | 36,036 | -2.4% | 0.01% | 0.0% |
Q4 2017 | $6,576,000 | +39.2% | 36,919 | +7.3% | 0.01% | +16.7% |
Q3 2017 | $4,723,000 | +43.0% | 34,392 | +9.4% | 0.01% | +50.0% |
Q2 2017 | $3,302,000 | +16.1% | 31,433 | +0.5% | 0.00% | 0.0% |
Q1 2017 | $2,843,000 | +71.3% | 31,282 | +16.3% | 0.00% | +100.0% |
Q4 2016 | $1,660,000 | -2.9% | 26,901 | +6.7% | 0.00% | -33.3% |
Q3 2016 | $1,709,000 | +56.9% | 25,209 | +0.2% | 0.00% | +50.0% |
Q2 2016 | $1,089,000 | +2492.9% | 25,166 | +2315.2% | 0.00% | – |
Q1 2016 | $42,000 | -28.8% | 1,042 | +13.5% | 0.00% | – |
Q4 2015 | $59,000 | -25.3% | 918 | 0.0% | 0.00% | – |
Q3 2015 | $79,000 | -49.4% | 918 | -0.8% | 0.00% | – |
Q2 2015 | $156,000 | -96.7% | 925 | -97.6% | 0.00% | -100.0% |
Q1 2015 | $4,732,000 | +274.4% | 39,184 | +184.3% | 0.01% | +200.0% |
Q4 2014 | $1,264,000 | +146.4% | 13,781 | -3.5% | 0.00% | +100.0% |
Q3 2014 | $513,000 | +5.3% | 14,277 | +13.1% | 0.00% | 0.0% |
Q2 2014 | $487,000 | +258.1% | 12,620 | +110.9% | 0.00% | – |
Q1 2014 | $136,000 | +17.2% | 5,984 | +7.8% | 0.00% | – |
Q4 2013 | $116,000 | +2800.0% | 5,552 | +3702.7% | 0.00% | – |
Q3 2013 | $4,000 | – | 146 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |